RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Clinical trials for RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to control tough ovarian cancer: Three-Way drug showdown
Disease control OngoingThis study is testing which combination of three drugs works best to control recurrent ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to standard platinum-based chemotherapy. It involves 444 patients and compares a standard two-drug combo agains…
Matched conditions: RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New hope for tough ovarian cancers: Triple-Drug attack tested
Disease control OngoingThis study is testing whether combining two or three newer drugs works better than standard chemotherapy for women whose ovarian, fallopian tube, or primary peritoneal cancer has returned and stopped responding to platinum-based drugs. It will involve about 120 women who have alr…
Matched conditions: RECURRENT FALLOPIAN TUBE CLEAR CELL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC